Join to View Full Profile
8950 Villa La Jolla DrSte C217La Jolla, CA 92037
Phone+1 858-869-8699
Fax+1 858-638-8142
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Kearney, MD is a board certified psychiatrist in La Jolla, California. She is currently licensed to practice medicine in California and New Jersey.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Child and Adolescent Psychiatry, 1988 - 1989- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1984 - 1988
Georgetown University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2016 - 2027
NJ State Medical License 1996 - 2017
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- 17 citationsPotentiating α2 subunit containing perisomatic GABAA receptors protects against seizures in a mouse model of Dravet syndrome.Toshihiro Nomura, Nicole A. Hawkins, Jennifer A. Kearney, Alfred L. George, Anis Contractor
The Journal of Physiology. 2019-08-01 - 32 citationsCaMKII modulates sodium current in neurons from epileptic Scn2a mutant miceChristopher H. Thompson, Nicole A. Hawkins, Jennifer A. Kearney, Alfred L. George
Proceedings of the National Academy of Sciences of the United States of America. 2017-02-14 - 114 citationsDe novo KCNB1 mutations in epileptic encephalopathy.Ali Torkamani, Kevin R. Bersell, Benjamin S. Jorge, Robert L. Bjork, Jennifer Friedman
Annals of Neurology. 2014-10-01
Press Mentions
'Mother of All Cannabinoids': Anti-Seizure Compounds Found in CannabisOctober 5th, 2021- Boston Researchers Using COVID-19 Patients’ DNA to Unlock Secrets About Impact of VirusJune 11th, 2020
Versius®: A New Paradigm in Robotic Assisted SurgeryMay 1st, 2020
Grant Support
- Genetic Mapping of Modifier Loci in a Mouse Model KCNB1 EncephalopathyNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Genetic Mapping of Modifier Loci in a Mouse Model KCNB1 EncephalopathyNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskIMMUNOCHEM THERAPEUTICS, LLC2021–2025
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskIMMUNOCHEM THERAPEUTICS, LLC2021–2025
- Genetic Modifiers of Childhood EpilepsyNORTHWESTERN UNIVERSITY AT CHICAGO2014–2025
